ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Mixed Modality (Peptide Downstream) Scientist at Eli Lilly and Company - ApplyBlast

Mixed Modality (Peptide Downstream) Scientist

Eli Lilly and Company

2 months ago

4.0 on Glassdoor

Carmel, Indiana, United States

Onsite

Full Time

Medior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Mixed Modality (Peptide Downstream) Scientist will evaluate and facilitate the transfer of peptide downstream manufacturing processes from development labs to pilot plant operations, supporting early‑phase cGMP manufacturing of API for clinical trials. The role involves performing peptide purification, preparing technical documentation, and contributing to process improvement and troubleshooting within the Lilly Medicine Foundry project.

Responsibilities

Evaluate and transfer peptide downstream manufacturing processes
Perform peptide purification and scale‑up experiments
Document technical transfers and support process troubleshooting

Skills

Qualifications

B.S. in ChemistryM.S. in ChemistryB.S. in Chemical Engineering

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.